Literature DB >> 15006902

Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats.

Glaucia E Callera1, Ester Yeh, Rita C A Tostes, Luciana C Caperuto, Carla R O Carvalho, Lusiane M Bendhack.   

Abstract

1. beta-Adrenoceptor (beta-AR)-mediated vasodilation, which plays an important physiological role in the regulation of vascular tone, is decreased in two-kidney, one clip (2K-1C) renal hypertension. In this study, downstream pathways related to vascular beta-AR activation were evaluated in 2K-1C rats. 2. Relaxation responses to isoprenaline, forskolin and 8-Br-cAMP were diminished in aortas without endothelium from 2K-1C when compared to those in normotensive two kidney (2K). Basal adenosine-3',5'-monophosphate (cAMP), as well as isoprenaline-induced increase in cAMP levels, was not different between 2K and 2K-1C aortas. 3. Contractile responses to caffeine, after depletion and reloading of intracellular Ca(2+) stores, were greater in 2K-1C than in 2K. The presence of isoprenaline during the Ca(2+)-reloading period abolished the differences between groups by increasing caffeine contraction in 2K without changing this response in 2K-1C aortas. Inhibition of the sarcolemmal Ca(2+)ATPase with thapsigargin markedly attenuated isoprenaline vasodilation in both 2K and 2K-1C and abolished the differences between groups. 4. Blockade of ATP-sensitive K(+) channels (K(ATP)) channels with glibenclamide significantly decreased isoprenaline vasodilation in 2K-1C without affecting this response in 2K. Both vascular gene and protein expression of protein kinase A (PKA), as well as phosphoserine-containing proteins, were increased in 2K-1C vs 2K rats. 5. In conclusion, decreased isoprenaline vasodilation in 2K-1C hypertensive rats is related to impaired modulation of the sarcolemmal Ca(2+)ATPase activity. Moreover, K(ATP) channels may play a compensatory role on isoprenaline-induced relaxation in renal hypertension. Both Ca(2+)ATPase and K(ATP) channel functional alterations, associated with decreased beta-AR vasodilation, are paralleled by an upregulation of protein kinase A (PKA) and phosphoserine proteins expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006902      PMCID: PMC1574885          DOI: 10.1038/sj.bjp.0705717

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats.

Authors:  K Fujii; U Onaka; K Goto; I Abe; M Fujishima
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

2.  Contribution of sarcoplasmic reticulum calcium uptake and L-type calcium channels to altered vascular responsiveness in the aorta of renal hypertensive rats.

Authors:  G E Callera; L M Bendhack
Journal:  Gen Pharmacol       Date:  1999-12

3.  G-Protein-coupled receptor kinase activity in hypertension : increased vascular and lymphocyte G-protein receptor kinase-2 protein expression.

Authors:  R Gros; J Chorazyczewski; M D Meek; J L Benovic; S S Ferguson; R D Feldman
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

4.  Endoplasmic reticulum contribution to the relaxant effect of cGMP- and cAMP-elevating agents in feline aorta.

Authors:  C Mundiña-Weilenmann; L Vittone; G Rinaldi; M Said; G C de Cingolani; A Mattiazzi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

Review 5.  Vascular beta-adrenoceptor function in hypertension and in ageing.

Authors:  E S Werstiuk; R M Lee
Journal:  Can J Physiol Pharmacol       Date:  2000-06       Impact factor: 2.273

6.  Evidence for reduced beta-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats.

Authors:  M Asano; K Masuzawa; T Matsuda
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

7.  Decreased relaxation of isolated mesenteric resistance vessels from 2-kidney, 1 clip Goldblatt hypertensive rats.

Authors:  C Cauvin; B Pegram
Journal:  Clin Exp Hypertens A       Date:  1983

8.  Cyclic nucleotides depress action potentials in cultured aortic smooth muscle cells.

Authors:  J M Ousterhout; N Sperelakis
Journal:  Eur J Pharmacol       Date:  1987-11-24       Impact factor: 4.432

9.  Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats.

Authors:  S Fujimoto; Y Dohi; K Aoki; T Matsuda
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

10.  Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.

Authors:  G Tsujimoto; C H Lee; B B Hoffman
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

View more
  4 in total

1.  Impaired β-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced K(Ca) channel activity.

Authors:  Takayuki Matsumoto; Theodora Szasz; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2012-02-21       Impact factor: 7.658

2.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

3.  Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.

Authors:  Yan Li; Xizhong Cui; Wanying Xu; Lernik Ohanjanian; Hanish Sampath-Kumar; Dante Suffredini; Mahtab Moayeri; Stephen Leppla; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-22       Impact factor: 4.733

4.  The Labdane Ent-3-Acetoxy-Labda-8(17), 13-Dien-15-Oic Decreases Blood Pressure In Hypertensive Rats.

Authors:  Janaina A Simplicio; Marilia R Simão; Sergio R Ambrosio; Carlos R Tirapelli
Journal:  Arq Bras Cardiol       Date:  2016-04-19       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.